PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE MKT: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug ...
An individual bottle of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10mg/500mg, NDC 0603-3888-20, 60 count, was found to be incorrectly labeled with a Phenobarbital Tablets, USP 32.4 mg, NDC ...
* Lannett Company Inc - plan to launch all of recently approved products in new fiscal year, which begins next week * Lannett Company-received approval from FDA of anda for hydrocodone bitartrate and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results